Other Income & Expense
Other Income (Expense)
Gilead Sciences Other Income (Expense) decreased by 38.7% to $349.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 4.7% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Significant fluctuations often relate to changes in interest rates, investment valuations, or currency volatility.
Detailed definition
The net total of income and expenses from non-operating activities, such as interest income, interest expense, and gains...
Peer comparison
Companies with large cash piles often show significant interest income here, while highly levered firms show interest expense.
Metric ID:
is_other_income_expense_netHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$173.00M | -$154.00M | $0.00 | -$111.00M | -$284.00M | -$176.00M | -$10.00M | -$135.00M | $152.00M | -$72.00M | $253.00M | $91.00M | -$355.00M | $306.00M | -$328.00M | $208.00M | $569.00M | $349.00M |
| QoQ Change | — | +11.0% | +100.0% | — | -155.9% | +38.0% | +94.3% | <-999% | +212.6% | -147.4% | +451.4% | -64.0% | -490.1% | +186.2% | -207.2% | +163.4% | +173.6% | -38.7% |
| YoY Change | — | — | — | — | -64.2% | -14.3% | — | -21.6% | +153.5% | +59.1% | >999% | +167.4% | -333.6% | +525.0% | -460.4% | +158.6% | +85.9% | — |
Range-$355.00M – $569.00M
CAGR+18.0%
Avg YoY Growth+240.5%
Median YoY Growth+72.5%
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's other income (expense)?
- Gilead Sciences (GILD) reported other income (expense) of $349.00M in Q4 2025.
- What is the long-term trend for Gilead Sciences's other income (expense)?
- Over 3 years (2021 to 2025), Gilead Sciences's other income (expense) has grown at a 4.7% compound annual growth rate (CAGR), from -$696.00M to $798.00M.
- What does other income (expense) mean?
- Money made or lost from activities not related to the company's main business, like investments or interest.